Found: 7
Select item for more details and to access through your institution.
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211010937
- By:
- Publication type:
- Article
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211010937
- By:
- Publication type:
- Article
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2137, doi. 10.3390/cancers13092137
- By:
- Publication type:
- Article
Qualification of tumour mutational burden by targeted next‐generation sequencing as a biomarker in hepatocellular carcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 192, doi. 10.1111/liv.14706
- By:
- Publication type:
- Article
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 583, doi. 10.1159/000519108
- By:
- Publication type:
- Article
Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms.
- Published in:
- Immunology, 2020, v. 159, n. 2, p. 167, doi. 10.1111/imm.13141
- By:
- Publication type:
- Article
T‐cell mediated responses against alpha‐foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients' survival.
- Published in:
- Liver Cancer International, 2021, v. 2, n. 1, p. 7, doi. 10.1002/lci2.22
- By:
- Publication type:
- Article